Mastercard Incorporated

MA· NYQ· Financial Services· Credit Services

$568.34

+0.12% Delayed prices.

The risks of investing in Mastercard Incorporated (MA)

From the Sep 26, 2026 report · Read the full report

Risks flagged in the analysis

  • High debt-to-equity ratio (439.58%) requires careful monitoring amid rising interest rates.
  • Forward PE of 24.65 implies growth must meet expectations to avoid downside pressure.
  • Valuation sensitivity to market sentiment as premium metrics reflect elevated growth expectations.

Bear case

  • Current price ($567.65) is below 50-day SMA ($568.82), indicating short-term bearish momentum.
  • Negative MACD (-$2.08) with contracting histogram ($-1.72) signals deteriorating short-term momentum.
  • Rising 10Y Treasury yield (5.18%) and mortgage rates near 7.5% may suppress consumer spending and transaction volumes.

Risk in numbers

Beta
0.74
Debt / equity
439.6
Annual volatility
22.3%
Largest fall in 12 months
-18.8%

52-week range

$464.52$601.23

Frequently asked questions

What are the risks of investing in MA?

High debt-to-equity ratio (439.58%) requires careful monitoring amid rising interest rates. Forward PE of 24.65 implies growth must meet expectations to avoid downside pressure. Valuation sensitivity to market sentiment as premium metrics reflect elevated growth expectations.

Sources: Yahoo Finance (prices, financial statements and analysts' estimates) and the U.S. Treasury (10-year yield). Indicators and valuation are computed without AI.

AI-generated informational content. Not financial advice or a personalised investment recommendation. Investing involves risk, including loss of capital.

Comparisons

VSell
vs
MAHold

V vs MA: Valuation vs. Strategic Growth

Visa (V) is rated SELL due to overvaluation and technical resistance, while Mastercard (MA) is rated HOLD with a focus on strategic growth initiatives. V's higher valuation (31.27x TTM PE) contrasts with MA's strategic positioning in stablecoin and AI commerce.

Every week, in your inbox

Rating changes, the highest-conviction stocks and the week's best research. Free.

By subscribing you accept the privacy policy. You can unsubscribe at any time.